MARKET

VCYT

VCYT

Veracyte
NASDAQ

Real-time Quotes | Nasdaq Last Sale

26.19
+1.52
+6.16%
Closed 16:10 10/21 EDT
OPEN
24.84
PREV CLOSE
24.67
HIGH
26.30
LOW
24.60
VOLUME
961.99K
TURNOVER
--
52 WEEK HIGH
31.18
52 WEEK LOW
9.20
MARKET CAP
1.27B
P/E (TTM)
-89.3552
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of VCYT and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 6 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

VCYT News

  • Veracyte Highlights Data Showing Clinical Validity Of Next-Gen Percepta Classifier Will Be Presented At American College of Chest Physicians Thurs.
  • Benzinga.12h ago
  • Veracyte Announces Clinical Data Demonstrating Clinical Validity and Utility of Percepta Classifier in Lung Cancer Diagnosis When Bronchoscopy Results Are Inconclusive
  • Business Wire.12h ago
  • Fiera Capital SMID Cap Growth Strategy Q3 2019 Commentary
  • Seeking Alpha - Article.17h ago
  • Veracyte Announces New Data Demonstrating That Envisia Genomic Classifier Improves IPF Diagnosis
  • Business Wire.18h ago

More

Industry

Biotechnology & Medical Research
+1.53%
Pharmaceuticals & Medical Research
+0.40%

Hot Stocks

Name
Price
%Change

About VCYT

Veracyte, Inc. is a genomic diagnostics company. The Company, through its scientific platform, which utilizes ribonucleic acid (RNA), whole-transcriptome sequencing combined with machine learning, produces genomic tests. It provides various genomic tests, including Afirma Genomic Sequencing Classifier (GSC), Percepta Bronchial Genomic Classifier, Envisia Genomic Classifier and Afirma Xpression Atlas. It provides GSC tests for thyroid cancer. It provides Percepta Bronchial Genomic Classifier tests for lung cancer. It provides Envisia Genomic Classifier tests for idiopathic pulmonary fibrosis (IPF). Its Afirma Xpression Atlas provides information on gene alterations associated with thyroid cancer, enabling physicians to tailor surgical and treatment decisions at time of diagnosis.
More

Webull offers Veracyte Inc (VCYT) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.